resveratrol has been researched along with Glioblastoma in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (4.44) | 29.6817 |
| 2010's | 30 (66.67) | 24.3611 |
| 2020's | 13 (28.89) | 2.80 |
| Authors | Studies |
|---|---|
| Du, JZ; Lin, XM; Liu, J; Nie, JH; Shi, XX; Xiong, L; Ye, HS | 1 |
| Ali, J; Baboota, S; Mittal, S | 1 |
| Mertoğlu Kamalı, E; Önay Uçar, E; Şengelen, A | 1 |
| Cheng, H; Du, R; Gao, F; Kong, J; Liang, P; Liu, H; Sun, F; Wang, G; Wang, H; Yi, G | 1 |
| Bagheri, H; Bahman, Y; Moliani, A; Mousavi, M; Zhang, Y; Zhang, Z | 1 |
| Ahmad, N; Cheng, X; Deng, S; Li, H; Shu, X; Song, D; Wang, Q; Wu, M; Xu, H; Yang, X | 1 |
| Aliashrafzadeh, H; Babaniamansour, S; Bahramvand, Y; Dianat-Moghadam, H; Jafarzadeh, E; Karkon-Shayan, S; Majidi, M; Moradi-Vastegani, S; Rastegar-Pouyani, N; Zarei, M | 1 |
| Andò, S; Chimento, A; Conforti, FL; D'Amico, M; De Amicis, F; Giordano, F; Malivindi, R; Montalto, FI; Panno, ML; Pezzi, V | 1 |
| Contreras-Ochoa, CO; Díaz-Chávez, J; Lagunas-Martínez, A; López-Arellano, ME; Madrid-Marina, V; Moreno-Banda, GL; Munguía-Moreno, JA; Reyna-Figueroa, J; Roblero-Bartolon, G | 1 |
| Liu, C; Ren, L; Wang, Z; Wei, Z; Xing, J; Xu, H; Zhao, L | 1 |
| Allegretti, M; Bastioli, F; Covino, S; de Luca, A; Dionigi, L; Fioretti, B; Iannitti, RG; Monarca, L; Moulas, AN; Ragonese, F | 1 |
| Ashrafizadeh, M; Farkhondeh, T; Mohammadinejad, R; Samarghandian, S | 1 |
| Cielecka-Piontek, J; Kaczmarek, M; Kleszcz, R; Krajka-Kuźniak, V; Majchrzak-Celińska, A; Paluszczak, J; Studzińska-Sroka, E; Wierzchowski, M; Zielińska-Przyjemska, M | 1 |
| Classen, CF; Fiedler, T; Kreikemeyer, B; Linnebacher, M; Maletzki, C; Riess, C; Rosche, Y; Scholz, A; William, D | 1 |
| Baidoo, JNE; Banerjee, P; Cohen, LS; David, L; Mancuso, A; Mukherjee, S; Sampat, S; Zhou, S | 1 |
| Deshpande, P; Jhaveri, A; Pattni, B; Torchilin, V | 1 |
| Blasiak, J; Pawlowska, E; Szatkowska, M; Szczepanska, J | 1 |
| Jia, B; Kong, QY; Li, H; Liu, J; Shu, XH; Song, X; Wu, ML; Zheng, X | 1 |
| Li, H; Lin, XM; Liu, J; Nie, JH; Wu, ML; Xiong, L | 1 |
| Braidy, N; Günaydın, C; Nazıroğlu, M; Öztürk, Y; Yalçın, F | 1 |
| Önay Uçar, E; Şengelen, A | 1 |
| Chen, Y; Cheng, Y; Cui, J; Li, Y; Lyu, X; Song, Y; Zhao, G; Zhao, L; Zheng, T | 1 |
| Agarwal, N; Bloom, L; Bregy, A; Gersey, Z; Komotar, RJ; Osiason, AD; Shah, S; Thompson, JW | 1 |
| Bueno e Silva, MM; Filippi-Chiela, EC; Garicochea, B; Ledur, PF; Lenz, G; Pelegrini, AL; Thomé, MP; Zamin, LL | 1 |
| Bogeas, A; Chneiweiss, H; Dubois, LG; El-Habr, EA; Junier, MP; Lipecka, J; Sayd, S; Tahiri-Jouti, N; Thirant, C | 1 |
| Chen, XY; Kong, QY; Li, H; Liu, J; Shi, S; Shu, XH; Sun, Z | 1 |
| Firouzi, F; Khoei, S; Mirzaei, HR | 1 |
| Chen, XY; Gu, JY; Kong, QY; Li, H; Liu, J; Shi, S; Shu, XH; Song, X; Wang, LL; Wu, ML | 1 |
| Cao, Y; Guo, A; Jiao, Y; Li, H; Li, Y; Liu, Y; Qu, X; Wang, S; Xu, X; Zhao, J | 2 |
| Barone, A; Jackson, E; Kim, AH; Leonard, JR; Marasa, J; Piwnica-Worms, D; Rao, S; Rubin, JB; Sengupta, R; Taylor, S; Warrington, NM | 1 |
| Liang, Z; Long, L; Wang, L; Wang, W | 1 |
| Bhattacharya, S; Clark, PA; Darjatmoko, SR; Elmayan, A; Kuo, JS; Polans, AS; Thuro, BA; van Ginkel, PR; Yan, MB | 1 |
| Hong, L; Jia, L; Jia-Yao, G; Jie, B; Li-Li, W; Lin, S; Mo-Li, W; Pei-Nan, L; Peng, Z; Qian, W; Qing-You, K; Shun, S; Xiao-Hong, S; Xiao-Yan, C; Xue, S | 1 |
| Castino, R; Isidoro, C; Lah, TT; Morani, F; Peracchio, C; Pucer, A; Veneroni, R | 1 |
| Chang, CH; Chang, CJ; Chang, YL; Chen, MH; Chen, MT; Chiou, GY; Chiou, SH; Hsu, CC; Huang, PI; Ma, HI; Shih, YH; Tsai, LL; Tseng, LM; Wang, CT; Yang, YP; Yu, CC | 1 |
| Filippi-Chiela, EC; Lenz, G; Villodre, ES; Zamin, LL | 1 |
| Cheng, J; Huang, H; Lin, H; Liu, B; Xiong, W; Zhang, W; Zhang, X; Zhang, Y | 1 |
| Chen, XY; Kong, QY; Li, C; Li, H; Liu, J; Shu, XH; Sun, XX; Sun, Z; Wang, Q; Wu, ML | 1 |
| Huang, H; Li, J; Lin, H; Zhang, X | 1 |
| Guo, RB; Hu, G; Sun, XL; Xue, X; Yuan, Y | 1 |
| Chen, XY; Kong, QY; Li, H; Liu, J; Shi, H; Shu, XH; Sun, Z; Wu, ML | 1 |
| Baumgärtner, W; Empl, MT; Lapp, S; Macke, S; Puff, C; Steinberg, P; Stoica, G; Winterhalter, P | 1 |
| Bertelli, AA; Gagliano, N; Gioia, M; Magnani, I; Moscheni, C; Torri, C | 1 |
| Cornetta, T; Cozzi, R; Fiore, M; Lauro, MG; Leone, S; Pino, S | 1 |
5 review(s) available for resveratrol and Glioblastoma
| Article | Year |
|---|---|
Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Phosphatidylinositol 3-Kinases; Resveratrol | 2023 |
Focus on the Use of Resveratrol as an Adjuvant in Glioblastoma Therapy.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Glioblastoma; Humans; Matrix Metalloproteinase 2; Phosphatidylinositol 3-Kinases; Resveratrol | 2020 |
Protective Effect of Resveratrol against Glioblastoma: A Review.
Topics: Antineoplastic Agents; Cell Proliferation; Central Nervous System Neoplasms; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Protective Agents; Resveratrol | 2021 |
An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Autophagy; Brain Neoplasms; Cellular Senescence; Dacarbazine; Disease Models, Animal; DNA Damage; Glioblastoma; Humans; Mice; Resveratrol; Stilbenes; Temozolomide | 2018 |
Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme.
Topics: ADAM Proteins; Amyloid Precursor Protein Secretases; Antineoplastic Agents; Arsenic Trioxide; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Gene Knockdown Techniques; Glioblastoma; Humans; Inhibitor of Differentiation Proteins; Kruppel-Like Transcription Factors; MicroRNAs; Microvessels; Molecular Targeted Therapy; Neoplasm Proteins; Netrin-1; Niclosamide; Receptors, Notch; Receptors, Urokinase Plasminogen Activator; Resveratrol; Signal Transduction; Tretinoin | 2019 |
40 other study(ies) available for resveratrol and Glioblastoma
| Article | Year |
|---|---|
Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.
Topics: Animals; Apoptosis; Brain Neoplasms; Capsules; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Liberation; Glioblastoma; Humans; Interleukin-13 Receptor alpha2 Subunit; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Rats; Resveratrol; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
DoE Engineered Development and Validation of an RP-HPLC Method for Simultaneous Estimation of Temozolomide and Resveratrol in Nanostructured Lipid Carrier.
Topics: Acetic Acid; Chromatography, High Pressure Liquid; Drug Stability; Excipients; Glioblastoma; Humans; Limit of Detection; Methanol; Reproducibility of Results; Resveratrol; Temozolomide | 2022 |
Hsp27, Hsp60, Hsp70, or Hsp90 depletion enhances the antitumor effects of resveratrol via oxidative and ER stress response in human glioblastoma cells.
Topics: Endoplasmic Reticulum Stress; Glioblastoma; Glioma; Heat-Shock Proteins; HEK293 Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Oxidative Stress; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering | 2023 |
Intratumor Injection of Thermosensitive Polypeptide with Resveratrol Inhibits Glioblastoma Growth.
Topics: Animals; Elastin; Glioblastoma; Interferons; Mice; Peptides; Resveratrol | 2023 |
Resveratrol inhibits glioblastoma cells and chemoresistance progression through blockade P-glycoprotein and targeting AKT/PTEN signaling pathway.
Topics: ATP Binding Cassette Transporter, Subfamily B; Brain Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Signal Transduction | 2023 |
Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Glioblastoma; Humans; Molecular Chaperones; Protein Inhibitors of Activated STAT; Resveratrol; STAT3 Transcription Factor; Suppressor of Cytokine Signaling Proteins; Temozolomide | 2023 |
Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Neoplastic Stem Cells; Resveratrol; Signal Transduction | 2023 |
Molecular mechanisms of cell death induced in glioblastoma by experimental and antineoplastic drugs: New and old drugs induce apoptosis in glioblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytes; Caspases; Cell Line, Tumor; Cell Survival; Cisplatin; Etoposide; Glioblastoma; Humans; Leupeptins; Mice; Resveratrol; Tumor Suppressor Protein p53 | 2020 |
Pak2 inhibition promotes resveratrol-mediated glioblastoma A172 cell apoptosis via modulating the AMPK-YAP signaling pathway.
Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinases; Apoptosis; Caspase 9; Cell Line, Tumor; Cell Survival; Glioblastoma; Humans; MAP Kinase Signaling System; Mitochondria; p21-Activated Kinases; Reactive Oxygen Species; Resveratrol; Signal Transduction; Transcription Factors; YAP-Signaling Proteins | 2020 |
Methoxy-stilbenes downregulate the transcription of Wnt/β-catenin-dependent genes and lead to cell cycle arrest and apoptosis in human T98G glioblastoma cells.
Topics: Antioxidants; Apoptosis; beta Catenin; Cell Cycle Checkpoints; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Resveratrol; Stilbenes; Tumor Cells, Cultured; Wnt1 Protein | 2021 |
Deciphering molecular mechanisms of arginine deiminase-based therapy - Comparative response analysis in paired human primary and recurrent glioblastomas.
Topics: Autophagy; Bacterial Proteins; Cell Line, Tumor; Cell Survival; Cellular Senescence; Curcumin; Gamma Rays; Glioblastoma; Heat-Shock Proteins; Humans; Hydrolases; Quinacrine; Recombinant Proteins; Resveratrol; Stilbenes; Streptococcus pyogenes; Superoxide Dismutase; Up-Regulation | 2017 |
Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells.
Topics: Animals; Biomarkers, Tumor; Catechin; Cell Line, Tumor; Curcumin; Disease Models, Animal; Drug Combinations; Drug Synergism; Glioblastoma; Humans; Immunophenotyping; Killer Cells, Natural; Liposomes; Lymphocytes, Tumor-Infiltrating; Macrophages; Mice; Microglia; Neoplastic Stem Cells; Resveratrol; Stilbenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2018 |
Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Female; Glioblastoma; Humans; Liposomes; Mice; Mice, Nude; Receptors, Transferrin; Resveratrol; Treatment Outcome | 2018 |
Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas.
Topics: Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Intracranial Hypertension; Neoplasm Recurrence, Local; Prognosis; Rats; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes | 2018 |
Differential Exosomic Proteomic Patterns and Their Influence in Resveratrol Sensitivities of Glioblastoma Cells.
Topics: Cell Line, Tumor; Exosomes; Gene Ontology; Glioblastoma; Humans; Neoplasm Proteins; Proteomics; Resveratrol | 2019 |
Resveratrol Enhances Apoptotic and Oxidant Effects of Paclitaxel through TRPM2 Channel Activation in DBTRG Glioblastoma Cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Glioblastoma; Humans; Oxidants; Paclitaxel; Reactive Oxygen Species; Resveratrol; TRPM Cation Channels | 2019 |
Resveratrol and siRNA in combination reduces Hsp27 expression and induces caspase-3 activity in human glioblastoma cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Gene Silencing; Glioblastoma; Heat-Shock Proteins; Humans; Molecular Chaperones; Quercetin; Resveratrol; RNA, Small Interfering | 2019 |
Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling.
Topics: Animals; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glioblastoma; Heterografts; Humans; Mice; Mitogen-Activated Protein Kinase 7; Resveratrol; Signal Transduction; Smad Proteins; SOXB1 Transcription Factors; Transforming Growth Factor beta1 | 2019 |
Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Autophagy; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cellular Senescence; Checkpoint Kinase 2; Cyclin B; Dacarbazine; DNA Damage; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Histones; Humans; Mitosis; Nuclear Proteins; Phosphorylation; Protein-Tyrosine Kinases; Resveratrol; Stilbenes; Temozolomide; Time Factors | 2013 |
Sirtuin-2 activity is required for glioma stem cell proliferation arrest but not necrosis induced by resveratrol.
Topics: Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Glioblastoma; Humans; Necrosis; Neoplastic Stem Cells; Resveratrol; RNA, Small Interfering; Sirtuin 2; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain; Cell Line, Tumor; Cell Proliferation; Enzyme Induction; Glioblastoma; Glucuronides; Glucuronosyltransferase; Humans; Male; Metabolic Detoxication, Phase II; Neoplasm Proteins; Nerve Tissue Proteins; Neurons; Rats; Rats, Wistar; Resveratrol; Species Specificity; Stilbenes; Sulfotransferases; Sulfuric Acid Esters | 2013 |
Role of resveratrol on the cytotoxic effects and DNA damages of iododeoxyuridine and megavoltage radiation in spheroid culture of U87MG glioblastoma cell line.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Glioblastoma; Humans; Idoxuridine; Resveratrol; Stilbenes; Tetrazolium Salts; Thiazoles; Trypan Blue; X-Rays | 2015 |
Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications.
Topics: Analysis of Variance; Animals; Anticarcinogenic Agents; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glucuronosyltransferase; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2015 |
Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Survival; Dacarbazine; Down-Regulation; Glioblastoma; Humans; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Transplantation; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Temozolomide | 2015 |
Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions.
Topics: Animals; Brain Neoplasms; Cell Communication; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Endothelial Cells; Female; Glioblastoma; Humans; Mice, Nude; Phytotherapy; Plant Extracts; Protamines; Resveratrol; Small Molecule Libraries; Spirostans; Stilbenes; Survival Analysis; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation.
Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Neoplastic Stem Cells; Phosphorylation; Resveratrol; Signal Transduction; Stilbenes; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo.
Topics: AC133 Antigen; Animals; Antigens, CD; Apoptosis; Autophagy; Biomarkers, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; DNA Damage; Glioblastoma; Glycoproteins; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Peptides; Radiation Tolerance; Radiation-Sensitizing Agents; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2015 |
Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Female; Glioblastoma; Humans; Male; Mice; Mice, Inbred BALB C; Resveratrol; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2017 |
Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioblastoma; Magnetic Resonance Imaging; Rats; Resveratrol; Signal Transduction; Spinal Puncture; STAT3 Transcription Factor; Stilbenes | 2016 |
Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Differentiation; Cell Division; Cell Line, Tumor; Glioblastoma; Humans; Microscopy, Fluorescence; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Wound Healing | 2011 |
Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Astrocytoma; Brain Neoplasms; Chemoradiotherapy; Female; Glioblastoma; Humans; Male; Mice; Mice, SCID; Middle Aged; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |
Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells.
Topics: Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Neoplastic Stem Cells; Phagosomes; Resveratrol; Stilbenes | 2011 |
Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Astrocytes; bcl-2-Associated X Protein; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Genes, p53; Glioblastoma; Humans; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptor, Notch1; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53 | 2011 |
Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies.
Topics: Animals; Apoptosis; Arylsulfotransferase; Cell Line, Tumor; Cells, Cultured; Glioblastoma; Humans; Immunohistochemistry; Molecular Chaperones; Protein Inhibitors of Activated STAT; Rats; Resveratrol; STAT3 Transcription Factor; Stilbenes; Sulfotransferases; Tyrphostins | 2011 |
Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Down-Regulation; Drug Combinations; Drug Resistance, Neoplasm; Glioblastoma; Humans; NF-kappa B; Resveratrol; Stilbenes; Temozolomide; Tumor Suppressor Proteins | 2012 |
Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents, Alkylating; Calcium-Binding Proteins; Cell Line, Tumor; Dacarbazine; Drug Synergism; Drug Therapy, Combination; Female; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, Nude; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Temozolomide; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2012 |
Distinct sulfonation activities in resveratrol-sensitive and resveratrol-insensitive human glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Arylsulfotransferase; Blotting, Western; Brain Neoplasms; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Flow Cytometry; Glioblastoma; Humans; Immunoenzyme Techniques; Mass Spectrometry; Neoplasm Grading; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Sulfonic Acids; Sulfotransferases; Tissue Array Analysis; Tumor Cells, Cultured | 2012 |
The growth of the canine glioblastoma cell line D-GBM and the canine histiocytic sarcoma cell line DH82 is inhibited by the resveratrol oligomers hopeaphenol and r2-viniferin.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dogs; Glioblastoma; Histiocytic Sarcoma; Molecular Structure; Phenols; Polyphenols; Resveratrol; Stilbenes | 2014 |
Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and Secreted Protein Acidic and Rich in Cysteine (SPARC) on human cultured glioblastoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Glioblastoma; Humans; Matrix Metalloproteinase 2; Osteonectin; Resveratrol; RNA, Messenger; Stilbenes | 2005 |
Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Communication; Cell Cycle; Cell Line, Tumor; Cell Survival; Connexin 43; Gap Junctions; Glioblastoma; Humans; Microscopy, Fluorescence; Mutation; Resveratrol; Stilbenes; X-Rays | 2008 |